Your browser doesn't support javascript.
loading
Early objective response may not be a prognostic factor of survival for patients with metastatic urothelial carcinoma: from a retrospective analysis of a cohort of 113 patients.
Roubaud, Guilhem; Brouste, Véronique; Beuzeboc, Phillipe; Fléchon, Aude; Tosi, Diego; Lavau-Denes, Sandrine; Chevreau, Christine; Culine, Stéphane; Oudard, Stéphane; Quivy, Amandine; Pourquier, Philippe; Houédé, Nadine.
Afiliação
  • Roubaud G; Department of Medical Oncology, Institut Bergonié, 229, Cours de l'Argonne, 33076, Bordeaux, France. g.roubaud@bordeaux.unicancer.fr.
  • Brouste V; Institut Bergonié, Clinical and Epidemiological Research Unit, 33000, Bordeaux, France. v.brouste@bordeaux.unicancer.fr.
  • Beuzeboc P; Department of Medical Oncology, Institut Curie, 25 rue d'Ulm, 75005, Paris, France. philippe.beuzeboc@curie.net.
  • Fléchon A; Department of Medical Oncology, Institut Léon Berard, 69000, Lyon, France. aude.flechon@lyon.unicancer.fr.
  • Tosi D; Department of Medical Oncology, Institut Val d'Aurelle, 34000, Montpellier, France. diego.tosi@icm.unicancer.fr.
  • Lavau-Denes S; Department of Medical Oncology, CHU Dupuytren, 87000, Limoges, France. sandrine.lavau-denes@chu-limoges.fr.
  • Chevreau C; Department of Medical Oncology, Institut Claudius Regaud, 31000, Toulouse, France. chevreau.christine@iuct-oncopole.fr.
  • Culine S; Centre Hospitalier Universitaire Saint Louis, 75010, Paris, France. stephane.culine@sls.aphp.fr.
  • Oudard S; European Hospital Georges Pompidou, 75015, Paris, France. stephane.oudard@aphp.fr.
  • Quivy A; Department of Medical Oncology, Institut Bergonié, 229, Cours de l'Argonne, 33076, Bordeaux, France. amandine.quivy@chu-bordeaux.fr.
  • Pourquier P; Institut de Recherche en Cancérologie de Montpellier & Université de Montpellier 1, INSERM U896, F-34000, Montpellier, France. philippe.pourquier@inserm.fr.
  • Houédé N; Department of Medical Oncology, Institut Bergonié, 229, Cours de l'Argonne, 33076, Bordeaux, France. nadine.houede@chu-nimes.fr.
J Negat Results Biomed ; 14: 18, 2015 Nov 10.
Article em En | MEDLINE | ID: mdl-26555878
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Urológicas / Cisplatino / Antineoplásicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Urológicas / Cisplatino / Antineoplásicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article